Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders' Equity

v3.10.0.1
Consolidated Statements of Shareholders' Equity - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Capital Stock
Warrants
Contributed Surplus [Member]
Accumulated Other Comprehensive Income
Deficit
Total
Beginning Balance at Dec. 31, 2017 $ 177,063 $ 4,109 $ 15,454 $ 3,663 $ (161,508) $ 38,781
Beginning Balance (in shares) at Dec. 31, 2017 146,531,933         146,531,933
Exercise of stock options $ 353   (106)     $ 247
Exercise of stock options (in shares) 420,344,000         420,344
Common shares issued for cash, net $857 of issue costs $ 7,443         $ 7,443
Common shares issued for cash, net of issue costs (in shares) 12,195,122         1,536,169
Redemption of vested RSUs     (12)     $ (12)
Expiry of warrants   $ (4,109) 4,109      
Non-cash stock compensation     727     727
Net loss and comprehensive (loss) income       (22) 6,200 6,178
Ending Balance at Sep. 30, 2018 $ 184,859   $ 20,172 $ 3,641 $ (155,308) $ 53,364
Ending Balance (in shares) at Sep. 30, 2018 159,147,399         159,147,399